Differentiation of BCS-TC2 human colon adenocarcinoma cells by sodium butyrate: Increase in 5'-nucleotidase activity

European Journal of Clinical Investigation

Volumn 27, Issue 7, 1997, Pages 620-628

  Navarro, J M ^a   Olmo, N ^a   Turnay, J ^a   Lopez Conejo M T ^a   Lizarbe, M A ^a  

^a UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

Author keywords

Apoptosis; Colon cancer; Epithelial differentiation markers; Short chain fatty acids

Indexed keywords

5' NUCLEOTIDASE; ALKALINE PHOSPHATASE; BUTYRIC ACID; CARCINOEMBRYONIC ANTIGEN;

APOPTOSIS; ARTICLE; CELL DIFFERENTIATION; CELL SIZE; CELL VACUOLE; COLON ADENOCARCINOMA; CONTROLLED STUDY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN CONTENT;

EID: 0030750008     PISSN: 00142972     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2362.1997.1510698.x     Document Type: Article

References (43)

1. Mortensen PB, Clausen MR. Short-chain fatty acids in the human colon: relation to gastrointestinal health and disease. Scand J Gastroenterol 1996;31:132-48.
2. Scheppach W, Bartram HP, Richter F. Role of short-chain fatty acids in the prevention of colorectal cancer. Eur J Cancer 1995;31A:1077-80.
3. McIntyre A, Gibson PR, Young GP. Butyrate production from dietary fibre and protection against large bowel cancer in a rat model. Gut 1993;34:386-91.
4. Fantini J, Rognoni JB, Roccabianca M, Pommier G, Marvaldi J. Suramin inhibits cell growth and glycolytic activity and triggers differentiation of human colic adenocarcinoma cell clone HT29-D4. J Biol Chem 1989;264:10282-6.
5. Barnard JA, Warwick G. Butyrate rapidly induces growth differentiation in HT-29 cells. Cell Growth Different 1993;4:495-501.
6. Gamet L, Daviaud D, Denis-Pouxviel C, Rémésy Ch, Murat JC. Effects of short-chain fatty acids on growth and differentiation of the human colon cancer cell line HT29. Int J Cancer 1992;52:286-9.
7. Goldberg Y, Nassif II, Pittas A et al. The anti-proliferative effect of sulindac and sulindac sulfide on HT-29 colon cancer cells: alterations in tumor suppressor and cell cycle-regulatory proteins. Oncogene 1996;12:893-901.
8. Gum JR, Kam K, Byrd JC, Hicks JW, Sleisenger MH, Kim YS. Effects of sodium butyrate on human colonic adenocarcinoma cells. Induction of placental-like alkaline phosphatase. J Biol Chem 1987;262:1092-7.
9. Schroy P, Rustgi AK, Ikonomu E et al. Growth and intestinal differentiation are independently regulated in HT29 colon cancer cells. J Cell Physiol 1994;161:111-23.
10. Stein J, Schröder O, Bonk M, Oremek G, Lorenz M, Caspary WF. Induction of glutathione-S-transferase-pi by short-chain fatty acids in the intestinal cell line caco-2. Eur J Clin Invest 1996;26:84-7.
11. Zweibaum A, Pinto M, Chevalier G et al. Enterocytic differentiation of a subpopulation of the human colon tumor cell line HT-29 selected for growth in sugar free medium and its inhibition by glucose. J Cell Physiol 1985;122:21-9.
12. Turnay J, Olmo N, Gavilanes JG, Benitez J, Lizarbe MA. Establishment and characterization of a new human colon adenocarcinoma cell line: BCS-TC2. Cytotechnology 1990;3:75-88.
13. López-Conejo T, Olmo N, Turnay J, Navarro J, Lizarbe MA. Characterization of tumorigenic sublines from a poorly tumorigenic human colon adenocarcinoma cell line. Int J Cancer 1996;67:668-75.
14. Tsao D, Shi Z, Wong A, Kim YS. Effect of sodium butyrate on carcinoembryonic antigen production by human colonic adenocarcinoma cells in culture. Cancer Res 1983;43:1217-22.
15. Colony PC, Neutra MR. Epithelial differentiation in the foetal rat colon: plasma membrane phosphatase activities. Dev Biol 1983;97:349-63.
16. Chorváth B, Sedlák J. Hemopoietic cell differentiation antigens (CD system) 1993. Neoplasma 1994;41:193-6.
17. Amano S, Hazama F, Kawai J, Sasahara M. Increased 5′-nucleotidase activity induced by dibutyryl cyclic AMP treatment of cultured glial cells. Brain Res 1990;506:254-8.
18. Heilbronn A, Maienschein V, Carstensen K, Gann W, Zimmermann H. Crucial role of 5′-nucleotidase in differentiation and survival of developing neural cells. Neuroreport 1995;7:257-61.
19. Zimmermann H. 5′-Nucleotidase: molecular structure and functional aspects. Biochem J 1992;285:345-65.
20. Bradford MA. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein dye binding. Anal Biochem 1976;72:248-54.
21. Tumay J, Olmo N, Risse G, von der Mark K, Lizarbe MA. 5′-Nucleotidase activity in cultured cell lines. Effect of different assay conditions and correlation with cell proliferation. In Vitro Cell Dev Biol 1989;25:1055-61.
22. Smith CA, Williams GT, Kingston R, Jenkinson KJ, Owen JJT. Antibodies to CD3/T-cell receptor complex induce death by apoptosis in immature T cells in thymic cultures. Nature 1989;337:181-4.
23. Prado IB, Laudanna AA, Carneiro CRW. Susceptibility of colorectal carcinoma cells to natural killer mediated lysis: relationship to CEA expression and degree of differentiation. Int J Cancer 1995;61:854-60.
24. Toribara NW, Sack TL, Gum JR et al. Heterogeneity in the induction and expression of carcinoembryonic antigen-related antigens in human colon cancer cell lines. Cancer Res 1989;49:3321-7.
25. Ohannesian DW, Lotan D, Lotan R. Concomitant increases in Galeclin-1 and its glycoconjugale ligands (carcinoembryonic antigen, Lamp-1, and Lamp-2) in cultured human colon carcinoma cells by sodium butyrate. Cancer Res 1994;54:5992-6000.
26. Larsen JK, Christensen IJ, Kieler J. Cell cycle perturbation by sodium butyrate in tumorigenic and non-tumorigenic urothelial cell lines assessed by flow cytometric bromodeoxyuridine/DNA analysis. Cell Prolif 1995;28:359-71.
27. Huet Ch, Sahuquillo-Merino C, Coudrier E, Louvard D. Absorptive and mucus-secreting subclones isolated from a multipotent intestinal cell line (HT-29) provide new models for cell polarity and terminal differentiation. J Cell Biol 1987;105:345-57.
28. Lesufflleur T, Barbat A, Dussaulix E, Zweibaum A. Growth adaptation to methotrexate of HT-29 human colon carcinoma cells is associated with their ability to differentiate into columnar absorptive and mucus-secreting cells. Cancer Res 1990;50:6334-43.
29. Scaly L, Chalkley R. The effect of sodium butyrate on histone modification. Cell 1978;14:115-21.
30. Deng G, Liu G, Hu H, Gum JR, Kim YS. Transcriptional regulation of the human placental-like alkaline phosphatase gene and mechanisms involved in its induction by sodium butyrate. Cancer Res 1992;52:3378-83.
31. Heerdt BG, Houston MA, Augenlicht LH. Potentiation by specific short-chain fatty acids of differentiation and apoptosis in human colonic carcinoma cell lines. Cancer Res 1994;54:3288-94.
32. Hague A, Manning AM, Hanlon KA, Huschtscha LI, Hart D, Paraskeva C. Sodium butyrate induces apoptosis in human colonic tumor cell lines in a p53-independent pathway: implications for the possible role of dietary fibre in the prevention of large-bowel cancer. Int J Cancer 1993;55:498-505.
33. Hague A, Elder DJE, Hicks DJ, Paraskeva C. Apoptosis in colorectal tumour cells: induction by the short chain fatty acids butyrate. propionate and acetate and by the hile salt deoxycholate. Int J Cancer 1995;60:400-6.
34. Thomas GL, Henley A, Rowland TC, Sahal A, Griffin M, Birckbichler PJ. Enhanced apoptosis in transformed human lung fibroblasts after exposure to sodium butyrate. In Vitro Cell Dev Biol 1996;32:505-13.
35. McBain JA, Eastman A, Simmons DL, Pettit GR, Mueller GC. Phorbol ester augments butyrate-induced apoptosis of colon cancer cells. Int J Cancer 1996;67:715-23.
36. Allan DJ, Howell A, Roberts SA et al. Reduction in apoptosis relative to mitosis in histologically normal epithelium accompanies fibrocystic change and carcinoma of the premenopausal human breast. J Pathol 1992;167:25-32.
37. Kerr JFK, Winterford CM, Harmon BV. Apoptosis. Us significance in cancer and cancer therapy. Cancer 1994;73:2013-26.
38. Chung YS, Song IS, Erickson RH, Sleisinger MH, Kim YS. Effect of growth and sodium butyrate on brush border membrane-associated hydrolases in human colorectal cancer cell lines. Cancer Res 1985;45:2976-82.
39. Herz F, Halwer M. Modulation of alkaline phosphatases in LoVo, a human colon carcinoma cell line. Biochim Biophys Acta 1989;1013:259-65.
40. Zoref-Shani E, Lavie R, Bromberg Y et al. Effects of differentiation-inducing agents on purine nucleotide metabolism in an ovarian cancer cell line. J Cancer Res Clin Oncol 1994;120:717-22.
41. Prager MD, Kanar MC. Effect of dimethylsulfoxide and butyrate on 5′-nuclcotidase of human renal carcinoma cells. Cancer Lett 1984;24:81-8.
42. Olmo N, Turnay J, Risse G, Deutzmann R, von der Mark K, Lizarbe MA. Modulation of 5′-nucleotidase activity in plasma membranes and intact cells by extracellular matrix proteins laminin and fibronectin. Biochem J 1992;282:181-8.
43. Horiuti Y, Yano K, Shibuya Y. Hormonal regulations of alkaline phosphatase, 5′-nucleotidase and γ-glutamyltransferase activities in adult rat hepatocytes cultured in serum-free medium on collagen gel. Cell Struct Funct 1993;18:73-8.